Gilead Sciences Inc
NASDAQ: GILD
$88.70
-$3.42 (-3.7%)
Real Time Data Delayed 15 Min.
GILD Articles
ThinkstockInsider selling is starting to get massive before year-end when higher capital gains taxes will kick in. We continue to expect that corporate insiders, venture backers, private equity...
Published:
Last Updated:
The stock market is mixed Wednesday, with the Dow Jones Industrial Average up 0.06%, the Nasdaq down 0.03% and the S&P 500 up 0.11%. Today’s winners are two pharmaceutical companies, one...
Published:
Last Updated:
Fortune is out with its top 10 stock picks for 2013. The list was divulged on CNBC late on Wednesday afternoon and was based on a survey of fund managers based upon solid companies with solid...
Published:
Last Updated:
The list of the best stocks of 2012 on the S&P 500 Index is one which makes sense in some cases and doesn’t in other cases. Some of these are simply recovery situations from lows but a few are...
Published:
Last Updated:
The stock market is down Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq down 0.02% and the S&P 500 down 0.01%. Today’s winners include two companies getting bought out and...
Published:
Last Updated:
ThinkstockWhen biotech stocks become as big as some of the second-tier drug stocks, it represents billions of dollars worth of value when these move 5% or 10%. That is exactly what we are seeing on...
Published:
Last Updated:
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena...
Published:
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals...
Published:
Last Updated:
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from...
Published:
Last Updated:
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement date....
Published:
Key research changes have been made in the last few days over at Bank of America/Merrill Lynch’s research coverage. The firm published its 2013 target for an S&P 500 Index target of 1,600 last...
Published:
Last Updated:
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short...
Published:
Apple Inc. (NASDAQ: AAPL) pushes for a ban on eight Samsung phones. (Reuters) Best Buy Co. Inc. (NYSE: BBY) will allow former chairman Richard Schulze to review its books with an eye toward a buyout...
Published:
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short...
Published:
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the period...
Published: